Contracts › 75N93023C00044
75N93023C00044: Development of Vaccines for Influenza Using an Immuno-Modulator Adjuvant and Multi-Platform Approach
Awarded to The University of Chicago by National Institutes of Health (NIH).
$9.3Mobligated
$9.3Mpotential value
29 September 2028current end date
See modifications, all subcontractors and funding in FedSift →
| Contract | 75N93023C00044 |
|---|---|
| Awardee | The University of Chicago |
| Awarding agency | National Institutes of Health (NIH) |
| Awarding office | NATIONAL INSTITUTES OF HEALTH NIAID |
| NAICS | 541512 Computer Systems Design Services |
| PSC | AN12 Health R&D Services; Health Care Services; Applied Research |
| Place of performance | IL |
| Offers received | 24 |
| Period of performance | 30 September 2023 to 29 September 2028 |
| Potential end | 29 September 2028 |
| Estimated recompete solicitation | ~Q2 2028 (estimate, ~6 months before expiry) |
Source: USASpending.gov (FPDS), public federal procurement data, as the agency reported it. Our record updated 03 October 2026. The solicitation date is an estimate from the end date, not a posted date.
Other expiring 541512 contracts · All expiring contracts · USASpending record